Sheel Bio. Stock Price Today (NSE: SHEEL)

Sheel Bio.

58.002.00 (3.33%)
Market Closed

Fundamental Score

...

Sheel Bio. Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Sheel Bio. share price today is 58.00, down 3.33% on NSE/BSE as of 22 September 2026. Sheel Bio. (SHEEL) is a Small-cap company in the Diversified Commercial Services sector with a market capitalisation of 146.53 (Cr). The 52-week high for SHEEL share price is 64.50 and the 52-week low is 57.35. At a P/E ratio of 12.46x, SHEEL is currently trading below its industry average P/E of 19.79x. The company has a Return on Equity (ROE) of 14.03% and a debt-to-equity ratio of 0.32.

Sheel Bio. Share Price Chart — NSE/BSE Historical Performance

No data
High
64.50
Low
58.00
Volume
8.0K
Change
-2.97%

Sheel Bio. share price chart: -2.97% return over the past month. 52-week high ₹64.50, 52-week low ₹57.35.

Sheel Bio. — Last 10 Trading Days

DateOpenHighLowCloseVolume
60.0060.0060.0060.004.00K (Cr)
60.0060.0060.0060.002.00K (Cr)
58.3060.0058.3060.0026.00K (Cr)
59.3061.0058.9061.0016.00K (Cr)
59.0062.6559.0062.006.00K (Cr)
58.8560.0058.6060.008.00K (Cr)
59.4561.6058.8561.6012.00K (Cr)
63.0063.0061.6061.606.00K (Cr)
64.0064.5064.0064.5012.00K (Cr)
61.3561.6561.3561.654.00K (Cr)

Sheel Bio. — Last 12 Months Price History

MonthOpenHighLowCloseChange
64.0064.5058.3060.00-6.25%
63.9563.9558.7561.65-3.60%

Returns & Performance

Poor

Return on Equity (ROE)

14.03%

Profit generated per ₹1 of shareholder equity

Average

Return on Capital (ROCE)

15.73%

Returns generated on total capital deployed

Good

Oper. Profit Margin (5Y Avg)

12.26%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Sheel Bio. Valuation Check

Excellent

Price to Earnings (P/E)

12.46x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

19.79x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

72.30%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Average

DII Holding

9.49%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

105.03%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

93.71%

Revenue growth vs same quarter last year

Good

Revenue Growth (5-Year CAGR)

11.80%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-12.62%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

20.13%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.32x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

8.34x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-7.99 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Sheel Bio. Fundamental Analysis & Valuation Benchmarking

Educational evaluation of SHEEL across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Excellent ROCE Performance (15.73%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Attractive Valuation (P/E: 12.46 vs Industry: 19.79)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (105.03%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (93.71%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Strong Profit Growth Track Record (20.13% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Strong Interest Coverage (8.34x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (72.30%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Weak Earnings Growth (-12.62% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Negative Free Cash Flow (₹-7.99 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 9.49%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Sheel Bio. vs Diversified Commercial Services Peers

Peer Comparison -

Compare Sheel Bio. with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
60.5/100
58
₹146.53
12.5
Average
14.03%
Average
15.73%
Good
0.3
Excellent
20.13%
Excellent
11.80%
Good
0.00%
72.2/100
312
₹13500.68
22.1
Average
23.22%
Excellent
30.72%
Excellent
0.0
Excellent
67.78%
Excellent
48.99%
Excellent
0.71%
44/100
677
₹9381.85
107.6
Average
29.74%
Excellent
20.57%
Excellent
1.1
Average
16.26%
Excellent
30.59%
Excellent
0.00%
68.3/100
1090
₹7679.05
18.4
Average
14.67%
Average
17.01%
Good
0.0
Excellent
19.07%
Excellent
26.21%
Excellent
0.64%
61/100
16
₹7318.76
22.6
Average
23.06%
Excellent
16.17%
Good
0.1
Excellent
36.58%
Excellent
37.68%
Excellent
0.00%
50.4/100
178
₹7151.34
57.3
Average
5.57%
Poor
8.46%
Poor
0.1
Excellent
21.46%
Excellent
10.28%
Good
0.00%
10.1/100
135
₹6185.81
65.4
Average
2.47%
Poor
5.08%
Poor
0.6
Good
5.66%
55.7/100
529
₹6044.51
216.8
Average
3.30%
Poor
8.30%
Poor
0.4
Excellent
17.02%
Excellent
45.06%
Excellent
0.00%
63.3/100
620
₹5787.56
16.7
Average
83.82%
Excellent
30.77%
Excellent
2.5
Poor
22.12%
Excellent
16.12%
Excellent
4.04%
53.2/100
353
₹5272.41
20.8
Average
19.69%
Good
18.65%
Good
0.0
Excellent
30.80%
Excellent
7.15%
Good
3.41%
43.1/100
206
₹4357.67
-42.16%
Poor
6.38%
Poor
0.6
Good
37.57%
Excellent
0.00%

Sheel Bio. Quarterly Performance

Latest quarterly metrics for SHEEL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

93.71%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

105.03%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

11.80%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

20.13%

Compounded annual net profit growth over 5 years

Sheel Bio. Technical Indicators

SMA 50, SMA 200, RSI and volume signals for SHEEL — calculated from daily price history

30-Day Avg Volume
8K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Sheel Bio. Financial Statements

Annual income statement, balance sheet and cash flow for Sheel Bio. (SHEEL) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Sheel Bio.

Loading latest quarterly results...

About SHEEL (Sheel Bio.)

Sheel Bio. (SHEEL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Diversified Commercial Services sector with ...a current market capitalisation of ₹146.53 (Cr). Sheel Bio. has delivered a Return on Equity (ROE) of 14.03% and a ROCE of 15.73%. The debt-to-equity ratio stands at 0.32, reflecting the company's capital structure. Investors tracking SHEEL share price can monitor key metrics including P/E ratio, promoter holding of 72.30%, and quarterly earnings growth.

Company Details

Symbol:SHEEL
Industry:Diversified Commercial Services
Sector:N/A
Website:N/A

SHEEL Share Price: Frequently Asked Questions

What is the current share price of Sheel Bio.?

Sheel Bio. (SHEEL) trades at ₹58.00 on NSE. Market cap ₹146.53 (Cr). Educational data only.

What is the P/E ratio of Sheel Bio.?

Sheel Bio. has a P/E of 12.46x vs industry average 19.79x.

What is the Bull Run score for Sheel Bio.?

Sheel Bio. has a Bull Run score of 60.5/100 based on 25+ financial parameters.

Does Sheel Bio. pay dividends?

Sheel Bio. has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Sheel Bio.?

Sheel Bio. has ROE of 14.03%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Sheel Bio.?

Sheel Bio. has debt-to-equity of 0.32.

Is Sheel Bio. a good investment?

Bull Run gives Sheel Bio. a score of 60.5/100. This is not investment advice — consult a SEBI-registered advisor.